Valion Bio announces 1-for-25 reverse stock split effective Aug. 31
VBIO•Reverse stock split details
Valion Bio said it will implement a 1-for-25 reverse stock split effective Aug. 31 at 12:01 a.m. ET.
Shares are expected to begin trading on a split-adjusted basis at the open on Aug. 31 under Nasdaq symbol VBIO.
The move is intended to help the company meet Nasdaq’s $1 minimum bid-price rule, and Valion Bio faces a Sept. 15 compliance deadline.
Fractional shares will be rounded up to whole shares, and no cash will be paid for fractions.
The post-split common stock CUSIP will be 918942202.
